Jorgensen Biotech Consulting ApS — Credit Rating and Financial Key Figures
CVR number: 42981761
Ermelundsvej 90 A, 2820 Gentofte
Income statement (kDKK)
2022 | 2023 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | 3 531.25 | 2 388.01 |
| Employee benefit expenses | -3 282.32 | -2 070.52 |
| EBIT | 248.94 | 317.49 |
| Other financial income | 0.08 | |
| Other financial expenses | -2.18 | -0.79 |
| Pre-tax profit | 246.76 | 316.78 |
| Income taxes | -54.46 | -69.86 |
| Net earnings | 192.30 | 246.92 |
Assets (kDKK)
2022 | 2023 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Inventories total | ||
| Current trade debtors | 327.90 | 286.75 |
| Current amounts owed by group member comp. | 23.17 | 19.20 |
| Current other receivables | 20.84 | |
| Short term receivables total | 351.06 | 326.79 |
| Cash and bank deposits | 180.49 | 995.30 |
| Cash and cash equivalents | 180.49 | 995.30 |
| Balance sheet total (assets) | 531.55 | 1 322.10 |
Equity and liabilities (kDKK)
2022 | 2023 | |
|---|---|---|
| Share capital | 40.00 | 40.00 |
| Shares repurchased | 117.80 | 122.00 |
| Retained earnings | - 117.80 | -47.50 |
| Profit of the financial year | 192.30 | 246.92 |
| Shareholders equity total | 232.30 | 361.42 |
| Non-current liabilities total | ||
| Current trade creditors | 15.95 | 28.37 |
| Short-term deferred tax liabilities | 54.46 | 69.86 |
| Other non-interest bearing current liabilities | 228.84 | 862.44 |
| Current liabilities total | 299.25 | 960.68 |
| Balance sheet total (liabilities) | 531.55 | 1 322.10 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.